Formed in 2010, the National MTM Advisory Board brings together representatives from multiple stakeholder groups to build consensus and influence policy development in the Medication Therapy Management (MTM) industry. The Board incorporates a diverse mix of viewpoints and experience from payers and pharmacy providers. As thought leaders, members of the board address both the short- and long-term positioning of MTM services within the larger healthcare picture. OutcomesMTM, a Cardinal Health company, provides administrative support to the board.
Board members come together to build consensus on important industry advancements. The board submits comments to CMS on rule changes, weighs in on quality measure developments and contributes to definitions to key industry terms.